Key result
Ca(2+)-sensitizers targeting cardiac troponin C offer potential inotropic and vasodilatory benefits for heart failure treatment, with structural studies suggesting new directions for rational drug design.
Design
Review
Authors
Loading...
May offer inotropic-vasodilatory benefits in HF; leaves open clinical role pending trials.
Ca2+-sensitizers targeting cardiac troponin C represent a promising class of inotropic agents for heart failure with potential advantages over traditional inotropes, including lower oxygen consumption and reduced arrhythmia risk.
Arteaga et al. (2002) conducted a review in Heart failure. Ca(2+)-sensitizers was evaluated. Ca(2+)-sensitizers targeting cardiac troponin C offer potential inotropic and vasodilatory benefits for heart failure treatment, with structural studies suggesting new directions for rational drug design.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: